Tyra Biosciences (TYRA) Retained Earnings (2020 - 2026)
Tyra Biosciences (TYRA) posted Retained Earnings of $107000.0 for Q1 2026, up 100.03% on a QoQ basis from -$371.3 million in Q4 2025, and up 100.04% year-over-year from $53489.8 in Q1 2025.
Tyra Biosciences (TYRA) Retained Earnings (2020 - 2026) Analysis & Trends
Tyra Biosciences' Retained Earnings history runs 7 years deep, the most recent figure standing at $107000.0 for Q1 2026.
- Quarterly Retained Earnings rose 100.04% year-over-year to $107000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $107000.0 (up 100.04% YoY) and the FY2025 annual result came in at -$371.3 million, down 47.73% from the prior year.
- Retained Earnings was $107000.0 for Q1 2026 at Tyra Biosciences, up from -$371.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at $1.8 million in Q3 2024 and bottomed at -$371.3 million in Q4 2025.
- A 5-year average of -$142.4 million and a median of -$107.6 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings jumped 101.23% — and 2025, when it sank 4657533.33%.
- Tyra Biosciences' Retained Earnings stood at -$95.7 million in 2022, then soared by 100.4% to $381000.0 in 2023, then sank by 66060.89% to -$251.3 million in 2024, then slumped by 47.73% to -$371.3 million in 2025, then surged by 100.03% to $107000.0 in 2026.
- Business Quant data shows TYRA's Retained Earnings at $107000.0 in Q1 2026, -$371.3 million in Q4 2025, and -$337.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - | 107,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | -371.26 Mn |
| Sep 30, 2025 | -337.42 Mn |
| Jun 30, 2025 | -307.56 Mn |
| Mar 31, 2025 | -279.46 Mn |
| Dec 31, 2024 | -251.31 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | -201.72 Mn |
| Mar 31, 2024 | -6,000.00 |
| Dec 31, 2023 | 381,000.00 |
| Sep 30, 2023 | -142.00 Mn |
| Jun 30, 2023 | -120.85 Mn |
| Mar 31, 2023 | -107.58 Mn |
| Dec 31, 2022 | -95.70 Mn |
| Sep 30, 2022 | -82.80 Mn |
| Jun 30, 2022 | -70.29 Mn |
| Mar 31, 2022 | -55.20 Mn |
| Dec 31, 2021 | -40.37 Mn |
| Sep 30, 2021 | -30.44 Mn |
| Dec 31, 2020 | -14.08 Mn |